Sale of 145 shares at $32.4681 per share.
Reporting Person Allan Jonathan · Officer Title GENERAL COUNSEL & CORP SEC · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001966716-26-000012 · filed 2026-08-18 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Stoke Therapeutics, Inc. (STOK)." Disclosed 2026-08-18. https://desqlong.com/cards/0001966716-26-000012-3 (retrieved 2026-09-26).